Wall street's assessment of plastic surgery-related technology: A clinical and financial analysis

Plastic and Reconstructive Surgery

Volumn 105, Issue 2, 2000, Pages 609-616

  Krieger, Lloyd M ^a   Shaw, William W ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; FINANCIAL MANAGEMENT; HOSPITAL COST; PLASTIC SURGERY; PRIORITY JOURNAL; PROFIT;

EID: 0033984134     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200002000-00020     Document Type: Article

References (54)

1. Malkiel, B. G. A Random Walk Down Wall Street. New York: W. W. Norton, 1990. Pp. 186-213.
2. Erich, A., and Helfert, E. A. Techniques of Financial Analysis. Homewood, Ill.: Irwin Professional Publishing, 1996.
3. Metcalf, G. E., and Malkiel, B. G. The Wall Street Journal contests: The experts, the darts, and the efficient market hypothesis. Appl. Finan. Econ. 4: 371, 1994.
4. Haugen, R. A. The New Finance: The Case Against Efficient Markets. New York: Prentice Hall, 1995.
5. Basu, S. Investment performance of common stocks in relation to their price-earnings ratios: A test of the efficient market hypothesis. J. Finan. 32: 663, 1977.
6. Dreman, D. Hard to forecast: Even the most careful earnings projections often go awry. Barron's. March 3, 1980. P. 29.
7. Engle, R. F., and Ng, V. K. Measuring and testing the impact of news on volatility. J. Finan. 48: 1749, 1993.
8. Theodossiou, P., and Lee, U. Mean and volatility spill-overs across major national stock markets: Further empirical evidence. J. Finan. Res. 16: 337, 1993.
9. Stickel, S. E. The anatomy of the performance of buy and sell recommendations. Finan. Anal. J. 51: 25, 1995.
10. Integra LifeSciences. Annual Report. Plainsboro, N.J.: Integra LifeSciences, 1997.
11. Integra LifeSciences. Form 10-K, 1997.
12. Genzyme Tissue Repair. Annual Report. Cambridge, Mass.: Genzyme Tissue Repair, 1997.
13. Genzyme Tissue Repair. Form 10-K, 1997.
14. LifeCell. Annual Report. The Woodlands, Texas: LifeCell, Inc., 1997.
15. LifeCell. Form 10-K, 1997.
16. Organogenesis. Annual Report. Canton, Mass.: Organogenesis, Inc., 1997.
17. Organogenesis. Form 10-K, 1997.
18. Advanced Tissue Sciences. Form 10-K, 1997.
19. Advanced Tissue Sciences. Annual Report. La Jolla, Calif.: Advanced Tissue Sciences, 1997.
20. Downes, J. Dictionary of Finance and Investment Terms. New York: Barron's Educational Series, 1998.
21. Bodie, Z., and Merton, R. C. Finance. New York: Prentice Hall, 1998.
22. Benninga, S. Z. Corporate Finance: A Valuation Approach. New York: McGraw Hill, 1996.
23. Blackburn, J. D., Klayman, E. I., and Malin, M. H. The Legal Environment of Business. Homewood, Ill.: Irwin Professional Publishing, 1991. Pp. 338-372.
24. Stone, D. K., and Lonergan, J. A. Perspectives: Genzyme Tissue Repair. Boston: Cowen & Co., 1996.
25. Kammeran, E. Integra LifeSciences: Wrestling for Sales. New York: Saloman Brothers, 1996.
26. Kammeran, E. Integra LifeSciences: On the Launch Pad. New York: Saloman Brothers, 1996.
27. Lind, D. D., and Leonard, C. R. Advanced Tissue Sciences: Near-Term Opportunity In Diabetic Foot Ulcers Market. New York: Morgan Stanley Dean Witter, 1997.
28. Ho, M., and Chiang, S. A. U.S. Research: Advanced Tissue Sciences. New York: Goldman Sachs, 1996.
29. Wang, E. T., and Huang W. Genzyme Tissue Repair: Solid Financial Results. New York: PaineWebber, 1996.
30. Swarz, J. R. Genzyme Tissue Repair. Boston: CS First Boston, 1996.
31. Arrow, A. K. Wound Healing and Artificial Skin Companies Industry Outlook. Los Angeles: Wedbush Morgan Securities, 1997.
32. Wall Street Journal. Interactive edition (www.wsj.com), accessed December 1, 1998.
33. Microsoft MoneyCentral. Internet Web Site (www.MoneyCentral.com.), accessed December 10, 1998.
34. Market Laboratory. Stocks. Barron's. December 21, 1998. P. 94.
35. Microsoft MoneyCentral Internet Web Site (WWW. MoneyCentral.com.), accessed December 20, 1998.
36. Dawson-Saunders, P., and Trapp, R. G. Basic and Clinical Biostatistics. Norwalk, Conn.: Appleton and Lange, 1990.
37. Zacks Earnings Estimates Report. New York: Zacks, Inc., 1998.
38. Bodie, Z., Kane, A., and Marcus, A.J. Investments. Homewood, Ill.: Irwin Professional Publishing, 1989. Pp. 92-95.
39. Krieger, L. M. The urge to merge: Health care enters the free market. Barron's. July 22, 1996. P. 42.
40. Personal communication. Jeffrey Anderson, Vice President Mellon Ventures, Los Angeles, December 1, 1998.
41. Kent, A. Insider trading. Barron's. January 25, 1988. P. 34.
42. Stickney, C. P. Financial Accounting. San Diego: Harcourt Brace Jovanovich, 1991. Pp. 481-509.
43. Wunder, G., and Mayo, H. Study supports efficient-market hypothesis. J. Finan. Plan. 8: 128, 1995.
44. Hansbrough, J. F., and Franco, E. S. Skin replacements. Clin. Plast. Surg. 25: 407, 1998.
45. Foster, G., Olsen, C., and Shevlin, T. Earnings releases, anomalies, and the behavior of security returns. The Accounting Rev. 59: 4, 1984.
46. Kim, S. T., Lin, J., and Slovin, M. B. Market structure, informed trading, and analysts' recommendations. J. Finan Quant. Anal. 32: 507, 1997.
47. Carleton, W. T., Chen, C. R., and Steiner, T. L. Optimism biases among brokerage and non-brokerage firms' equity recommendations: Agency costs in the investment industry. Finan Manag. April, 1998. P. 17.
48. Krieger, L. M. Price and service. Barron's. August 14, 1995. P. 47.
49. Kim, S. T., Lin, J., and Slovin, M. B. Market structure, informed trading, and analysts' recommendations. J. Finan. Quant. Anal. 32: 507, 1997.
50. Norris, F. What to do if your company's stock is over-valued. The NHV York Times. June 19, 1999. P. A26.
51. Pulliam, S., and Winslow, R. HMO's cost woes unsettle Wall Street. The Wall Street Journal, October 9, 1997. P. C1.
52. Krieger, L. M. Malpractice management. Barron's. November 30, 1998. P. 51.
53. Lowes, R. The PPM meltdown: How FPA's implosion buried its doctors. Medical Economics. February, 1999. P. 29.
54. Lowes, R. PPMs: Who will go bankrupt next? Medical Economics. February, 1999. P. 36.